Compare Bristol-Myers Squibb Co (BMY) vs PayPal Holdings, Inc. (PYPL) Price & Performance

Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.

BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.

PayPal (PYPL) trades at $47.65, up 2.87% on the day, with a bullish technical signal from moving averages but overbought RSI readings near 78. The stock shows strong fundamentals with a P/E of 8.94, net income margin of 15%, and consistent revenue growth to $33.17B in 2025. Recent news includes a potential acquisition offer from Stripe and Advent at $60.50 per share, valuing the company over $53 billion, alongside expansion of BNPL services in the UK.

PYPL presents a compelling value opportunity with low valuation multiples and solid profitability, though execution risks and competitive pressures remain. The acquisition speculation adds upside potential, but investors face volatility from earnings misses and regulatory scrutiny. Wall Street sentiment is mixed with a $48.36 consensus target, slightly above the current price.